79 related articles for article (PubMed ID: 18928585)
1. [Signal pathway in apoptosis of K562 cells induced by STI571].
Wang SY; Sun CH; Wei M; Ma WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1010-5. PubMed ID: 18928585
[TBL] [Abstract][Full Text] [Related]
2. [Effects of STI571 combined with As₂O₃ on proliferation, apoptosis and caspase 3, Bcl-xL expression of K562 cells].
Chen NY; Wang J; Wang XM; Zhang HX; Yan ZY; Wang YM; Zhang S; Yan B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):882-6. PubMed ID: 20723293
[TBL] [Abstract][Full Text] [Related]
3. [STI571 induces apoptosis of K562 cells through down-regulation of anti-apoptotic protein Mcl-1 and Bcl-xl expression].
Zhang BZ; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1182-5. PubMed ID: 18088462
[TBL] [Abstract][Full Text] [Related]
4. [Experimental research on tyrosine-kinase inhibitor STI571 and P21WAF gene clone to treat chronic myeloid leukemia].
Wang W; Sun BZ; Liu XP; Feng Q; Shang ZC; Cao YX; Yao LB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):737-42. PubMed ID: 15631651
[TBL] [Abstract][Full Text] [Related]
5. Effects of STI571 and p27 gene clone on proliferation and apoptosis of K562 cells.
Wang W; Yao LB; Liu XP; Feng Q; Shang ZC; Cao YX; Sun BZ
World J Gastroenterol; 2005 Apr; 11(14):2130-5. PubMed ID: 15810079
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
Yu C; Rahmani M; Almenara J; Subler M; Krystal G; Conrad D; Varticovski L; Dent P; Grant S
Cancer Res; 2003 May; 63(9):2118-26. PubMed ID: 12727828
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of K562 cell lines resistant to STI571 and a preliminary biological study].
Gao L; Wang JM; Xu XP; Chen L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):584-9. PubMed ID: 15498115
[TBL] [Abstract][Full Text] [Related]
9. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis.
Jakubowska J; Wasowska-Lukawska M; Czyz M
Eur J Pharmacol; 2008 Oct; 596(1-3):41-9. PubMed ID: 18782571
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell line K562.
Jakubowska J; Stasiak M; Szulawska A; Bednarek A; Czyz M
Acta Biochim Pol; 2007; 54(4):839-46. PubMed ID: 17957275
[TBL] [Abstract][Full Text] [Related]
11. Study on the treatment of the p15 gene combined with Bcr-abl-specific siRNA and STI571 for chronic myeloid leukemia.
Wang W; Du Y; Li NN; Lv FF; Lin GQ
Genet Mol Res; 2014 May; 13(2):4089-101. PubMed ID: 24938701
[TBL] [Abstract][Full Text] [Related]
12. [Influence of BCR-ABL inhibitor STI571 on SARI expression in K562 cells].
Huang Q; Li XQ; Yang Y; Huang SA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):865-8. PubMed ID: 21867603
[TBL] [Abstract][Full Text] [Related]
13. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism].
Shi DX; Ma LM; Lu YJ; Bai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):723-8. PubMed ID: 24989284
[TBL] [Abstract][Full Text] [Related]
14. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.
Yu C; Krystal G; Dent P; Grant S
Clin Cancer Res; 2002 Sep; 8(9):2976-84. PubMed ID: 12231544
[TBL] [Abstract][Full Text] [Related]
15. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
16. Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells.
Chen Y; Hu D
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):41-4. PubMed ID: 15165112
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative effect of the abl tyrosine kinase inhibitor STI571 on the P-glycoprotein positive K562/ADM cell line.
Kotaki M; Motoji T; Takanashi M; Wang YH; Mizoguchi H
Cancer Lett; 2003 Sep; 199(1):61-8. PubMed ID: 12963124
[TBL] [Abstract][Full Text] [Related]
18. Neferine increases STI571 chemosensitivity via inhibition of P-gp expression in STI571-resistant K562 cells.
Qin Q; Chen XP; Yang ZS; Xiao YH; Min H; Li YJ
Leuk Lymphoma; 2011 Apr; 52(4):694-700. PubMed ID: 21261505
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it.
Kawano T; Horiguchi-Yamada J; Iwase S; Furukawa Y; Kano Y; Yamada H
Mol Cell Biochem; 2004 Mar; 258(1-2):25-33. PubMed ID: 15030167
[TBL] [Abstract][Full Text] [Related]
20. Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes.
Czechowska A; Poplawski T; Drzewoski J; Blasiak J
Chem Biol Interact; 2005 Apr; 152(2-3):139-50. PubMed ID: 15840387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
